Cancer Proteomics: From Bench to Bedside (Cancer Drug Discovery and Development) - Image 1

£146.02

Humana Cancer Proteomics: From Bench to Bedside (Cancer Drug Discovery and Development)

Name: Cancer Proteomics: From Bench to Bedside (Cancer Drug Discovery and Development)
Brand: Humana
Price: 146.02 GBP
Availability: InStock

Diseases & Disorders

About as cheap as it gets. The only time it was cheaper was 2 months ago.

£146 today · all-time low £142 (May 2026) · usually £145

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 75 days · 75 data points (no recent data)

Historical

Generating forecast…

Price Distribution

Price distribution over 75 days • 6 price levels

Days at Price

Current Price

Price Analysis

Most common price: £143 (29 days, 38.7%)

Price range: £142 - £147

Price levels: 6 different prices over 75 days

Description

This book covers current topics related to the use of proteomic strategies in cancer therapy as well as anticipated challenges that may arise from its application in daily practice. It details current technologies used in proteomics, examines the use proteomics in cell signaling, presents clinical applications of proteomics in cancer therapy, and looks at the role of the FDA in regulating the use of proteomics. Review From the reviews: "This is a comprehensive overview of the current state of knowledge in the area of cancer proteomics … . appropriate for cancer researchers of diverse specialties and clinicians conducting basic or clinical cancer research. … a book that provides a truly comprehensive look at the utility of proteomics from ‘bench to bedside.’ All chapters are well referenced and of appropriate length, and many contain helpful illustrations. … an excellent book that is appropriate for scientists and clinicians with an interest in cancer proteomics." (John D. Robertson, Doody’s Review Service, May, 2008) "This book … provides the reader with a current perspective and anticipated uses of proteomic strategies in cancer therapy as well as basic cancer research. … the book provides a broad account of the area of cancer proteomics and adequately covers issues relevant to the use of proteomic strategies in clinical research. … The book would be of interest to clinicians and basic cancer researchers … who are already involved in, or who are considering the use of proteomics in their work." (JF Timms, British Journal of Cancer, Vol. 99 (4), 2008) From the Back Cover Over the past 20 years or so, there have been tremendous advances in our understanding of how normal cells transform to cancer and the importance of signaling pathways in cancer initiation and progression. Therefore, proteomics technologies must be improved for more global analysis of protein content of cells, tissues and body fluids as well as the posttranslational modifications to allow for proper detections and validation. In Cancer Proteomics, the authors collectively provide the current status of proteomics in cancer therapy and offers the existing technologies used in proteomics that allow for protein profiling and for the identification of druggable targets in human samples. Mass spectrometry based protein characterization and protein microarrays hold great promise of predicting response to specific drugs in cancer therapy. Insightful to the reader with broad perspectives on topics related to the use of proteomic strategies in cancer therapy, Cancer Proteomics offers anticipated challenges that may arise from its application in daily practice.

Product Specifications

Brand: Humana
Format: paperback
ASIN: 1617378070
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Diseases & Disorders
Domain: Amazon UK
Release Date: 09 December 2010
Listed Since: 01 October 2010

Barcode

No barcode data available

Humana Cancer Proteomics: From Bench to Bedside (Cancer Drug Discovery and Development)

About as cheap as it gets. The only time it was cheaper was 2 months ago.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Proteases and Cancer: Methods and Protocols: 539 (Methods in Molecular Biology, 539)

Clinical Oncoproteomics: Proteome-Based Personalized Anti-Cancer Therapy

Springer Modern Proteomics - Sample Prep and Analysis Manual

Proteome Research: Concepts, Technology and Application (Principles and Practice)

Functional Proteomics and Nanotechnology-Based Microarrays: 02 (Jenny Stanford Series on Nanobiotechnology)

Proteomics Data Analysis: 2361 (Methods in Molecular Biology, 2361)

Proteomics for Biomarker Discovery: 1002 (Methods in Molecular Biology, 1002)

Proteomics for Drug Discovery: Methods and Protocols: 1647 (Methods in Molecular Biology, 1647)

Proteases and Cancer: Methods and Protocols: 539 (Methods in Molecular Biology, 539)

Humana The Urinary Proteome: Methods and Protocols 641

LC-MS/MS in Proteomics: Methods and Applications: 658 (Methods in Molecular Biology, 658)

Computational Methods for Mass Spectrometry Proteomics

Proteomics: Biomedical and Pharmaceutical Applications

Statistical Analysis of Proteomic Data: Methods and Tools: 2426 (Methods in Molecular Biology, 2426)

Emerging Sample Treatments in Proteomics: 1073 (Advances in Experimental Medicine and Biology, 1073)

Proteolytic Signaling in Health and Disease

The Low Molecular Weight Proteome: Methods and Protocols: 1023 (Methods in Molecular Biology)

Proteomics Data Analysis: 2361 (Methods in Molecular Biology, 2361)

Neuroproteomics: 146 (Neuromethods, 146)

The Evolution from Protein Chemistry to Proteomics: Basic Science to Clinical Application

Mass Spectrometry Data Analysis in Proteomics: 2051 (Methods in Molecular Biology, 2051)

Mass Spectrometry Data Analysis in Proteomics: 2051 (Methods in Molecular Biology, 2051)

Proteomics Today: Protein Assessment and Biomarkers Using Mass Spectrometry, 2D Electrophoresis,and Microarray Technology: 7 (Wiley Series on Mass Spectrometry)

Quantitative Proteomics by Mass Spectrometry: 359 (Methods in Molecular Biology, 359)